167 related articles for article (PubMed ID: 34854362)
1. A potential paradigm shift in opioid crisis management: The role of pharmacogenomics.
Eapen-John D; Mohiuddin AG; Kennedy JL
World J Biol Psychiatry; 2022 Jul; 23(6):411-423. PubMed ID: 34854362
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomics of methadone: a narrative review of the literature.
Packiasabapathy S; Aruldhas BW; Horn N; Overholser BR; Quinney SK; Renschler JS; Sadhasivam S
Pharmacogenomics; 2020 Aug; 21(12):871-887. PubMed ID: 32705966
[No Abstract] [Full Text] [Related]
3. Individual variability in clinical effect and tolerability of opioid analgesics - Importance of drug interactions and pharmacogenetics.
Solhaug V; Molden E
Scand J Pain; 2017 Oct; 17():193-200. PubMed ID: 29054049
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of the U.S. opioid crisis: the importance of the vector.
Compton WM; Jones CM
Ann N Y Acad Sci; 2019 Sep; 1451(1):130-143. PubMed ID: 31378974
[TBL] [Abstract][Full Text] [Related]
5. Acute Pain and Development of Opioid Use Disorder: Patient Risk Factors.
Baumann L; Bello C; Georg FM; Urman RD; Luedi MM; Andereggen L
Curr Pain Headache Rep; 2023 Sep; 27(9):437-444. PubMed ID: 37392334
[TBL] [Abstract][Full Text] [Related]
6. Combating opioid addiction and abuse-2 ways to effectively intervene in the cycle of addiction through pharmacogenomics.
J Marcalus S; Bristow-Marcalus S
J Am Pharm Assoc (2003); 2019; 59(4):469-473. PubMed ID: 31126828
[TBL] [Abstract][Full Text] [Related]
7. The opioid epidemic.
Cook JL
Best Pract Res Clin Obstet Gynaecol; 2022 Dec; 85(Pt B):53-58. PubMed ID: 36045027
[TBL] [Abstract][Full Text] [Related]
8. Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: Current understanding and approaches to management.
Pergolizzi JV; Raffa RB; Rosenblatt MH
J Clin Pharm Ther; 2020 Oct; 45(5):892-903. PubMed ID: 31986228
[TBL] [Abstract][Full Text] [Related]
9. The Use of Oxytocin for the Treatment of Opioid Use Disorder.
Edinoff AN; Sall S; Honore LG; Dies RM; Zaheri AR; Kataria S; Jackson ED; Shekoohi S; Cornett EM; Murnane KS; Kaye AM; Kaye AD
Curr Pain Headache Rep; 2023 May; 27(5):89-97. PubMed ID: 37022563
[TBL] [Abstract][Full Text] [Related]
10. Relative addictive potential of opioid analgesic agents.
Connors NJ; Mazer-Amirshahi M; Motov S; Kim HK
Pain Manag; 2021 Mar; 11(2):201-215. PubMed ID: 33300384
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics of Opioid Use Disorder Treatment.
Crist RC; Clarke TK; Berrettini WH
CNS Drugs; 2018 Apr; 32(4):305-320. PubMed ID: 29623639
[TBL] [Abstract][Full Text] [Related]
12. Molecular and Epigenetic Aspects of Opioid Receptors in Drug Addiction and Pain Management in Sport.
Mazzeo F; Meccariello R; Guatteo E
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175536
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics and prediction of adverse events in prescription opioid use disorder patients.
Muriel J; Margarit C; Barrachina J; Ballester P; Flor A; Morales D; Horga JF; Fernández E; Peiró AM
Basic Clin Pharmacol Toxicol; 2019 Apr; 124(4):439-448. PubMed ID: 30549211
[TBL] [Abstract][Full Text] [Related]
14. Polysubstance use in the U.S. opioid crisis.
Compton WM; Valentino RJ; DuPont RL
Mol Psychiatry; 2021 Jan; 26(1):41-50. PubMed ID: 33188253
[TBL] [Abstract][Full Text] [Related]
15. Genetic addiction risk score (GARS) ™, a predictor of vulnerability to opioid dependence.
Blum K; Chen ALC; Thanos PK; Febo M; Demetrovics Z; Dushaj K; Kovoor A; Baron D; Smith DE; Roy AK; Fried L; Chen TJH; Chapman E; Modestino EJ; Steinberg B; Badgaiyan RD
Front Biosci (Elite Ed); 2018 Jan; 10(1):175-196. PubMed ID: 28930612
[TBL] [Abstract][Full Text] [Related]
16. Engaging pharmacogenomics in pain management and opioid selection.
Bright DR; Petry N; Roath E; Gibb T
Pharmacogenomics; 2021 Sep; 22(14):927-937. PubMed ID: 34521258
[TBL] [Abstract][Full Text] [Related]
17. The Opioid Crisis-Not Just Opioids Anymore.
Brent J; Weiss ST
JAMA Netw Open; 2022 Jun; 5(6):e2215432. PubMed ID: 35657631
[No Abstract] [Full Text] [Related]
18. Pharmacogenomics of Opioid Treatment for Pain Management.
Howes S; Cloutet AR; Kweon J; Powell TL; Raza D; Cornett EM; Kaye AD
Methods Mol Biol; 2022; 2547():491-504. PubMed ID: 36068474
[TBL] [Abstract][Full Text] [Related]
19. The opioid crisis: Origins, trends, policies, and the roles of pharmacists.
Chisholm-Burns MA; Spivey CA; Sherwin E; Wheeler J; Hohmeier K
Am J Health Syst Pharm; 2019 Mar; 76(7):424-435. PubMed ID: 31361827
[TBL] [Abstract][Full Text] [Related]
20. Adolescents and opioid-related outcomes amidst the COVID-19 pandemic.
Romero RA; Young SD
J Addict Dis; 2022; 40(1):126-130. PubMed ID: 33955321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
